NCT06934096
Ultrasound of the Spleen Utilizing Low-energy (Diagnostic Level) Insonification.
At risk: Primary completion moved at least 1 year 1 month later across 2 updates.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Eligibility criteria expanded, about 65 words
- Primary completion pushed from Jan 7, 2027 to Jun 7, 2027
- Study completion pushed from Jan 31, 2027 to Aug 31, 2027
- Site contact updated
Notable Primary completion pushed from Apr 21, 2026 to Jan 7, 2027v2 Show 4 more changesShow less
- Recruitment opened
- Start date changed from estimate of Apr 15, 2025 to Jan 8, 2026
- Study completion pushed from May 12, 2026 to Jan 31, 2027
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
To determine whether diagnostic-level ultrasound to the spleen can modulate systemic blood biomarkers of hemostasis
Timeframe: 4 hours
Arms and interventions
Focused insonification at enter of spleenExperimental
Prolonged duration Insonification at center of spleenExperimental
Prolonged insonification swept across the spleenExperimental
Devices: Ultrasound Pulsed Doppler Imaging System
Sites
1 site in 1 country
- Feinstein Institute for Medical ResearchManhasset, New York, United States